Francois Nader Moderna, Inc. (MRNA) insider trading activity

MRNA Quotes by TradingView

Francois Nader is Director of Moderna, Inc.. Currently has a direct ownership of 20,607 shares of MRNA, which is worth approximately $1.24 Million. The most recent transaction as insider was on May 10, 2022, when has been sold 3,196 shares (Common Stock) at a price of $136.1 per share, resulting in proceeds of $434,976. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K
0% 3M change
0% 12M change
Total Value Held $1.24 Million

Francois Nader Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2022
SELL
Open market or private sale
$434,976 $136.1 p/Share
3,196 Reduced 13.43%
20,607 Common Stock
May 10 2022
BUY
Exercise of conversion of derivative security
$435,897 $18.87 p/Share
23,100 Added 49.25%
23,803 Common Stock
Apr 28 2022
BUY
Exercise of conversion of derivative security
-
703 Added 50.0%
703 Common Stock

Also insider at

PRVL
Prevail Therapeutics Inc.
Director
XLRN
ACCELERON PHARMA INC Healthcare
Director
ALXN
ALEXION PHARMACEUTICALS, INC.
Director
TALS
Talaris Therapeutics, Inc. Healthcare
Director
FN

Francois Nader

Director
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNA